

Cardea Bio, a biotech company, has raised $7.5 million in Series A2 financing. The investors included Tsingyuan Ventures, Lifespan Investments and Serra Ventures.
Source: Press Release
Cardea Bio, a biotech company, has raised $7.5 million in Series A2 financing.
Cardea Bio, a biotech company, has raised $7.5 million in Series A2 financing. The investors included Tsingyuan Ventures, Lifespan Investments and Serra Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination